'' To good to be true''Here is the situation...
-You have this little unknown Canadian company(TLT), that pretend to have a treatment that is way better than most Big Pharma treatments that the FDA has already approved for Bladder cancer.
-This little unknown Canadian company(TLT), pretend that their treatment(Ruvidar) can cure cancer with only 1/2 treatments, versus 15/30 treatments for other Big Pharma FDA approved Bladder cancer treatments.
-This little unknown Canadian company(TLT) pretend that its cancer treatment(Ruvidar) can treat old and heavily pretreated Bladder cancer patients...
VALRUBICIN=NO
KEYTRUDA=NO
ADSTILADRIN=NO
CGO ONCOLOGY(CG0070)=NO
ANKTIVA(N803+BCG)=NO
TLT-RUVIDAR=YES
-This little unknown Canadian company(TLT) pretend that their treatment is 100% safe, all the above FDA approved treatments have some restrictions(restrictions indicate that your treatment is not safe for some type of patients), TLT-Ruvidar has no restrictions.
Put yourself in the place of the FDA evaluators, wouldn't you say ''sorry TLT your data numbers are to good to be true... please double check your +450 days data to make sure there is no mistakes''.
As we speak many longs on this board must be saying,Wow!...I have shares in this little unknown Canadian company that pretend to change the way cancer is treated.
For know the uniqueness of TLT- PDT treatment is slowing down the BTD approval process, but on the long run the uniqueness of TLT- Ruvidar will make this treatment superior to anything out there, and will increase big time the $value of a Big Pharma deal.
I love my TLT shares.